ClaPD regimen
|
WikiDoc Resources for ClaPD regimen |
|
Articles |
|---|
|
Most recent articles on ClaPD regimen Most cited articles on ClaPD regimen |
|
Media |
|
Powerpoint slides on ClaPD regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on ClaPD regimen at Clinical Trials.gov Trial results on ClaPD regimen Clinical Trials on ClaPD regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on ClaPD regimen NICE Guidance on ClaPD regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on ClaPD regimen Discussion groups on ClaPD regimen Patient Handouts on ClaPD regimen Directions to Hospitals Treating ClaPD regimen Risk calculators and risk factors for ClaPD regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for ClaPD regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
ClaPD regimen refers to a regimen consisting of Clarithromycin, Pomalidomide, Dexamethasone therapy in relapsed or refractory Multiple Myeloma
Regimen
ClaClarithromycin
PPomalidomide
DDexamethasone
Indications
- Relapsed or refractory Multiple Myeloma[1]